Ferric Citrate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 210 mg, 500mg
Reference Brands: Auryxia(US), Ferrozan(EU)
Category:
Nephrology
Ferric Citrate Tablets are dual‑action nephrology agents that bind dietary phosphate and deliver oral iron to manage hyperphosphatemia and anemia in CKD patients. Marketed as Auryxia® (US) and Ferrozan® (EU), they simplify renal care and enhance patient compliance.
Ferric Citrate Tablets is available in Tablet
and strengths such as 210 mg, 500mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ferric Citrate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ferric Citrate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ferric Citrate Tablets are an essential nephrology therapy for managing hyperphosphatemia and anemia in chronic kidney disease (CKD). As a dual‑action phosphate binder and oral iron supplement, ferric citrate reduces serum phosphate levels while delivering bioavailable iron to support erythropoiesis. Marketed as Auryxia® in the US and Ferrozan® in the EU, these tablets streamline CKD care by replacing separate phosphate binders and iron supplements. Ideal for Pharma B2B distributors and hospital procurement, our bulk supply meets FDA and EMA standards, offering cost‑effective renal care solutions. Boost your portfolio with high‑quality Ferric Citrate Tablets for global renal therapy markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing